◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Lincoln Pharmaceuticals Limited (LINCOLN) Financial History

Name: Lincoln Pharmaceuticals Limited (LINCOLN) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Lincoln Pharmaceuticals Limited (LINCOLN) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Ahmedabad, India with about 1,352 employees. Its market capitalization is roughly ₹12 billion. In the fiscal year ended 2026-03-31, LINCOLN reported ₹6.7B in revenue and ₹879M in net income.

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally.

Interactive charts & full statements →

LINCOLN Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹6.7B	₹6.2B	₹5.7B	₹5.0B	—
Gross Profit	₹3.6B	₹3.3B	₹2.9B	₹2.6B	—
Operating Income (EBIT)	₹832M	₹886M	₹896M	₹807M	—
Net Income	₹879M	₹824M	₹933M	₹729M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LINCOLN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹1.8B	₹1.9B	₹1.7B	₹1.6B	₹1.5B
Gross Profit	₹921M	₹982M	₹904M	₹866M	₹847M
Operating Income (EBIT)	₹236M	₹212M	₹199M	₹218M	₹203M
Net Income	₹362M	₹116M	₹286M	₹200M	₹277M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LINCOLN Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹36M)	(₹36M)	(₹30M)	(₹30M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LINCOLN Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹8.9B	₹8.0B	₹7.0B	₹5.9B	—
Total Liabilities	₹1.3B	₹1.3B	₹1.1B	₹850M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LINCOLN viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

FERMENTA · Fermenta Biotech Limited — ₹14 billion
4574 · Taiko Pharmaceutical Co.,Ltd. — JPY 13 billion
IPN · Ipsen S.A. — €13 billion
AHCL · Anlon Healthcare Limited — ₹12 billion
2627 · Ab&B Bio-Tech CO., LTD. JS — HK$12 billion
THEMISMED · Themis Medicare Limited — ₹12 billion
SIGACHI · Sigachi Industries Limited — ₹11 billion
BAJAJHCARE · Bajaj HealthCare Limited — ₹11 billion

← LINC All “L” companies LIND →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.